Watchlists Portfolios Alerts Pricing Sign in Get started

Menu

Kidpik Corp PIK

Full chart Compare

Set alert

2.38 USD 0.00 (+0.00%)

At closeFeb 10, 2026, 4:00 PM EST

2.38 Day range 2.38

1.75 52-week range 4.90

YTD: 0.00%
1 year: 0.00%

News

2 days ago businesswire.com Faeth Reports Positive Preliminary Phase 2 Topline Results from the PIK-201 Trial Evaluating PIKTOR in Combination with Paclitaxel in Patients with Advanced Endometrial Cancer AUSTIN, Texas--(BUSINESS WIRE)--Faeth Therapeutics (Nasdaq: FTH), a clinical-stage oncology company developing multi-node therapies for cancer patients, including its lead program PIKTOR, today…
5 days ago businesswire.com Faeth to Report PIK-201 Phase 2 Data and Host Virtual Event on November 9, 2026 AUSTIN, Texas--(BUSINESS WIRE)--Faeth Therapeutics (Nasdaq: FTH), a clinical- stage biotechnology company developing multi-node therapies for cancer patients, including its lead program PIKTOR, today…